Liver Failure Therapeutics and Forecast Market
1 Introduction to Research & Analysis Reports
1.1 Liver Failure Therapeutics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Liver Failure Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Liver Failure Therapeutics Overall Market Size
2.1 Global Liver Failure Therapeutics Market Size: 2021 VS 2028
2.2 Global Liver Failure Therapeutics Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Liver Failure Therapeutics Players in Global Market
3.2 Top Global Liver Failure Therapeutics Companies Ranked by Revenue
3.3 Global Liver Failure Therapeutics Revenue by Companies
3.4 Top 3 and Top 5 Liver Failure Therapeutics Companies in Global Market, by Revenue in 2021
3.5 Global Companies Liver Failure Therapeutics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Liver Failure Therapeutics Players in Global Market
3.6.1 List of Global Tier 1 Liver Failure Therapeutics Companies
3.6.2 List of Global Tier 2 and Tier 3 Liver Failure Therapeutics Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Liver Failure Therapeutics Market Size Markets, 2021 & 2028
4.1.2 Ornithine Phenylacetate
4.1.3 MTL-CEBPA
4.1.4 F-573
4.1.5 BL-1220
4.1.6 PP-100
4.1.7 Others
4.2 By Type - Global Liver Failure Therapeutics Revenue & Forecasts
4.2.1 By Type - Global Liver Failure Therapeutics Revenue, 2017-2022
4.2.2 By Type - Global Liver Failure Therapeutics Revenue, 2023-2028
4.2.3 By Type - Global Liver Failure Therapeutics Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Liver Failure Therapeutics Market Size, 2021 & 2028
5.1.2 Clinic
5.1.3 Hospital
5.1.4 Others
5.2 By Application - Global Liver Failure Therapeutics Revenue & Forecasts
5.2.1 By Application - Global Liver Failure Therapeutics Revenue, 2017-2022
5.2.2 By Application - Global Liver Failure Therapeutics Revenue, 2023-2028
5.2.3 By Application - Global Liver Failure Therapeutics Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Liver Failure Therapeutics Market Size, 2021 & 2028
6.2 By Region - Global Liver Failure Therapeutics Revenue & Forecasts
6.2.1 By Region - Global Liver Failure Therapeutics Revenue, 2017-2022
6.2.2 By Region - Global Liver Failure Therapeutics Revenue, 2023-2028
6.2.3 By Region - Global Liver Failure Therapeutics Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Liver Failure Therapeutics Revenue, 2017-2028
6.3.2 US Liver Failure Therapeutics Market Size, 2017-2028
6.3.3 Canada Liver Failure Therapeutics Market Size, 2017-2028
6.3.4 Mexico Liver Failure Therapeutics Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Liver Failure Therapeutics Revenue, 2017-2028
6.4.2 Germany Liver Failure Therapeutics Market Size, 2017-2028
6.4.3 France Liver Failure Therapeutics Market Size, 2017-2028
6.4.4 U.K. Liver Failure Therapeutics Market Size, 2017-2028
6.4.5 Italy Liver Failure Therapeutics Market Size, 2017-2028
6.4.6 Russia Liver Failure Therapeutics Market Size, 2017-2028
6.4.7 Nordic Countries Liver Failure Therapeutics Market Size, 2017-2028
6.4.8 Benelux Liver Failure Therapeutics Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Liver Failure Therapeutics Revenue, 2017-2028
6.5.2 China Liver Failure Therapeutics Market Size, 2017-2028
6.5.3 Japan Liver Failure Therapeutics Market Size, 2017-2028
6.5.4 South Korea Liver Failure Therapeutics Market Size, 2017-2028
6.5.5 Southeast Asia Liver Failure Therapeutics Market Size, 2017-2028
6.5.6 India Liver Failure Therapeutics Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Liver Failure Therapeutics Revenue, 2017-2028
6.6.2 Brazil Liver Failure Therapeutics Market Size, 2017-2028
6.6.3 Argentina Liver Failure Therapeutics Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Liver Failure Therapeutics Revenue, 2017-2028
6.7.2 Turkey Liver Failure Therapeutics Market Size, 2017-2028
6.7.3 Israel Liver Failure Therapeutics Market Size, 2017-2028
6.7.4 Saudi Arabia Liver Failure Therapeutics Market Size, 2017-2028
6.7.5 UAE Liver Failure Therapeutics Market Size, 2017-2028
7 Players Profiles
7.1 Alfact Innovation
7.1.1 Alfact Innovation Corporate Summary
7.1.2 Alfact Innovation Business Overview
7.1.3 Alfact Innovation Liver Failure Therapeutics Major Product Offerings
7.1.4 Alfact Innovation Liver Failure Therapeutics Revenue in Global Market (2017-2022)
7.1.5 Alfact Innovation Key News
7.2 BioLineRx Ltd
7.2.1 BioLineRx Ltd Corporate Summary
7.2.2 BioLineRx Ltd Business Overview
7.2.3 BioLineRx Ltd Liver Failure Therapeutics Major Product Offerings
7.2.4 BioLineRx Ltd Liver Failure Therapeutics Revenue in Global Market (2017-2022)
7.2.5 BioLineRx Ltd Key News
7.3 Cell2B Advanced Therapeutics SA
7.3.1 Cell2B Advanced Therapeutics SA Corporate Summary
7.3.2 Cell2B Advanced Therapeutics SA Business Overview
7.3.3 Cell2B Advanced Therapeutics SA Liver Failure Therapeutics Major Product Offerings
7.3.4 Cell2B Advanced Therapeutics SA Liver Failure Therapeutics Revenue in Global Market (2017-2022)
7.3.5 Cell2B Advanced Therapeutics SA Key News
7.4 Conatus Pharmaceuticals Inc
7.4.1 Conatus Pharmaceuticals Inc Corporate Summary
7.4.2 Conatus Pharmaceuticals Inc Business Overview
7.4.3 Conatus Pharmaceuticals Inc Liver Failure Therapeutics Major Product Offerings
7.4.4 Conatus Pharmaceuticals Inc Liver Failure Therapeutics Revenue in Global Market (2017-2022)
7.4.5 Conatus Pharmaceuticals Inc Key News
7.5 Immune Pharmaceuticals Inc
7.5.1 Immune Pharmaceuticals Inc Corporate Summary
7.5.2 Immune Pharmaceuticals Inc Business Overview
7.5.3 Immune Pharmaceuticals Inc Liver Failure Therapeutics Major Product Offerings
7.5.4 Immune Pharmaceuticals Inc Liver Failure Therapeutics Revenue in Global Market (2017-2022)
7.5.5 Immune Pharmaceuticals Inc Key News
7.6 Mina Therapeutics Ltd
7.6.1 Mina Therapeutics Ltd Corporate Summary
7.6.2 Mina Therapeutics Ltd Business Overview
7.6.3 Mina Therapeutics Ltd Liver Failure Therapeutics Major Product Offerings
7.6.4 Mina Therapeutics Ltd Liver Failure Therapeutics Revenue in Global Market (2017-2022)
7.6.5 Mina Therapeutics Ltd Key News
7.7 Mylan NV
7.7.1 Mylan NV Corporate Summary
7.7.2 Mylan NV Business Overview
7.7.3 Mylan NV Liver Failure Therapeutics Major Product Offerings
7.7.4 Mylan NV Liver Failure Therapeutics Revenue in Global Market (2017-2022)
7.7.5 Mylan NV Key News
7.8 Ocera Therapeutics Inc
7.8.1 Ocera Therapeutics Inc Corporate Summary
7.8.2 Ocera Therapeutics Inc Business Overview
7.8.3 Ocera Therapeutics Inc Liver Failure Therapeutics Major Product Offerings
7.8.4 Ocera Therapeutics Inc Liver Failure Therapeutics Revenue in Global Market (2017-2022)
7.8.5 Ocera Therapeutics Inc Key News
7.9 PledPharma AB
7.9.1 PledPharma AB Corporate Summary
7.9.2 PledPharma AB Business Overview
7.9.3 PledPharma AB Liver Failure Therapeutics Major Product Offerings
7.9.4 PledPharma AB Liver Failure Therapeutics Revenue in Global Market (2017-2022)
7.9.5 PledPharma AB Key News
7.10 Promethera Biosciences SA
7.10.1 Promethera Biosciences SA Corporate Summary
7.10.2 Promethera Biosciences SA Business Overview
7.10.3 Promethera Biosciences SA Liver Failure Therapeutics Major Product Offerings
7.10.4 Promethera Biosciences SA Liver Failure Therapeutics Revenue in Global Market (2017-2022)
7.10.5 Promethera Biosciences SA Key News
7.11 Silence Therapeutics Plc
7.11.1 Silence Therapeutics Plc Corporate Summary
7.11.2 Silence Therapeutics Plc Business Overview
7.11.3 Silence Therapeutics Plc Liver Failure Therapeutics Major Product Offerings
7.11.4 Silence Therapeutics Plc Liver Failure Therapeutics Revenue in Global Market (2017-2022)
7.11.5 Silence Therapeutics Plc Key News
7.12 Unicyte AG
7.12.1 Unicyte AG Corporate Summary
7.12.2 Unicyte AG Business Overview
7.12.3 Unicyte AG Liver Failure Therapeutics Major Product Offerings
7.12.4 Unicyte AG Liver Failure Therapeutics Revenue in Global Market (2017-2022)
7.12.5 Unicyte AG Key News
7.13 Ventria Bioscience
7.13.1 Ventria Bioscience Corporate Summary
7.13.2 Ventria Bioscience Business Overview
7.13.3 Ventria Bioscience Liver Failure Therapeutics Major Product Offerings
7.13.4 Ventria Bioscience Liver Failure Therapeutics Revenue in Global Market (2017-2022)
7.13.5 Ventria Bioscience Key News
7.14 Vital Therapies Inc
7.14.1 Vital Therapies Inc Corporate Summary
7.14.2 Vital Therapies Inc Business Overview
7.14.3 Vital Therapies Inc Liver Failure Therapeutics Major Product Offerings
7.14.4 Vital Therapies Inc Liver Failure Therapeutics Revenue in Global Market (2017-2022)
7.14.5 Vital Therapies Inc Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Liver Failure Therapeutics Market Opportunities & Trends in Global Market
Table 2. Liver Failure Therapeutics Market Drivers in Global Market
Table 3. Liver Failure Therapeutics Market Restraints in Global Market
Table 4. Key Players of Liver Failure Therapeutics in Global Market
Table 5. Top Liver Failure Therapeutics Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Liver Failure Therapeutics Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Liver Failure Therapeutics Revenue Share by Companies, 2017-2022
Table 8. Global Companies Liver Failure Therapeutics Product Type
Table 9. List of Global Tier 1 Liver Failure Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Liver Failure Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Liver Failure Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Liver Failure Therapeutics Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Liver Failure Therapeutics Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application ? Global Liver Failure Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Liver Failure Therapeutics Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Liver Failure Therapeutics Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region ? Global Liver Failure Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Liver Failure Therapeutics Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Liver Failure Therapeutics Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Liver Failure Therapeutics Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Liver Failure Therapeutics Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Liver Failure Therapeutics Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Liver Failure Therapeutics Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Liver Failure Therapeutics Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Liver Failure Therapeutics Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Liver Failure Therapeutics Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Liver Failure Therapeutics Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Liver Failure Therapeutics Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Liver Failure Therapeutics Revenue, (US$, Mn), 2023-2028
Table 30. Alfact Innovation Corporate Summary
Table 31. Alfact Innovation Liver Failure Therapeutics Product Offerings
Table 32. Alfact Innovation Liver Failure Therapeutics Revenue (US$, Mn), (2017-2022)
Table 33. BioLineRx Ltd Corporate Summary
Table 34. BioLineRx Ltd Liver Failure Therapeutics Product Offerings
Table 35. BioLineRx Ltd Liver Failure Therapeutics Revenue (US$, Mn), (2017-2022)
Table 36. Cell2B Advanced Therapeutics SA Corporate Summary
Table 37. Cell2B Advanced Therapeutics SA Liver Failure Therapeutics Product Offerings
Table 38. Cell2B Advanced Therapeutics SA Liver Failure Therapeutics Revenue (US$, Mn), (2017-2022)
Table 39. Conatus Pharmaceuticals Inc Corporate Summary
Table 40. Conatus Pharmaceuticals Inc Liver Failure Therapeutics Product Offerings
Table 41. Conatus Pharmaceuticals Inc Liver Failure Therapeutics Revenue (US$, Mn), (2017-2022)
Table 42. Immune Pharmaceuticals Inc Corporate Summary
Table 43. Immune Pharmaceuticals Inc Liver Failure Therapeutics Product Offerings
Table 44. Immune Pharmaceuticals Inc Liver Failure Therapeutics Revenue (US$, Mn), (2017-2022)
Table 45. Mina Therapeutics Ltd Corporate Summary
Table 46. Mina Therapeutics Ltd Liver Failure Therapeutics Product Offerings
Table 47. Mina Therapeutics Ltd Liver Failure Therapeutics Revenue (US$, Mn), (2017-2022)
Table 48. Mylan NV Corporate Summary
Table 49. Mylan NV Liver Failure Therapeutics Product Offerings
Table 50. Mylan NV Liver Failure Therapeutics Revenue (US$, Mn), (2017-2022)
Table 51. Ocera Therapeutics Inc Corporate Summary
Table 52. Ocera Therapeutics Inc Liver Failure Therapeutics Product Offerings
Table 53. Ocera Therapeutics Inc Liver Failure Therapeutics Revenue (US$, Mn), (2017-2022)
Table 54. PledPharma AB Corporate Summary
Table 55. PledPharma AB Liver Failure Therapeutics Product Offerings
Table 56. PledPharma AB Liver Failure Therapeutics Revenue (US$, Mn), (2017-2022)
Table 57. Promethera Biosciences SA Corporate Summary
Table 58. Promethera Biosciences SA Liver Failure Therapeutics Product Offerings
Table 59. Promethera Biosciences SA Liver Failure Therapeutics Revenue (US$, Mn), (2017-2022)
Table 60. Silence Therapeutics Plc Corporate Summary
Table 61. Silence Therapeutics Plc Liver Failure Therapeutics Product Offerings
Table 62. Silence Therapeutics Plc Liver Failure Therapeutics Revenue (US$, Mn), (2017-2022)
Table 63. Unicyte AG Corporate Summary
Table 64. Unicyte AG Liver Failure Therapeutics Product Offerings
Table 65. Unicyte AG Liver Failure Therapeutics Revenue (US$, Mn), (2017-2022)
Table 66. Ventria Bioscience Corporate Summary
Table 67. Ventria Bioscience Liver Failure Therapeutics Product Offerings
Table 68. Ventria Bioscience Liver Failure Therapeutics Revenue (US$, Mn), (2017-2022)
Table 69. Vital Therapies Inc Corporate Summary
Table 70. Vital Therapies Inc Liver Failure Therapeutics Product Offerings
Table 71. Vital Therapies Inc Liver Failure Therapeutics Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Liver Failure Therapeutics Segment by Type in 2021
Figure 2. Liver Failure Therapeutics Segment by Application in 2021
Figure 3. Global Liver Failure Therapeutics Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Liver Failure Therapeutics Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Liver Failure Therapeutics Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Liver Failure Therapeutics Revenue in 2021
Figure 8. By Type - Global Liver Failure Therapeutics Revenue Market Share, 2017-2028
Figure 9. By Application - Global Liver Failure Therapeutics Revenue Market Share, 2017-2028
Figure 10. By Region - Global Liver Failure Therapeutics Revenue Market Share, 2017-2028
Figure 11. By Country - North America Liver Failure Therapeutics Revenue Market Share, 2017-2028
Figure 12. US Liver Failure Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Liver Failure Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Liver Failure Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Liver Failure Therapeutics Revenue Market Share, 2017-2028
Figure 16. Germany Liver Failure Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 17. France Liver Failure Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Liver Failure Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Liver Failure Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Liver Failure Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Liver Failure Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Liver Failure Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Liver Failure Therapeutics Revenue Market Share, 2017-2028
Figure 24. China Liver Failure Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Liver Failure Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Liver Failure Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Liver Failure Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 28. India Liver Failure Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Liver Failure Therapeutics Revenue Market Share, 2017-2028
Figure 30. Brazil Liver Failure Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Liver Failure Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Liver Failure Therapeutics Revenue Market Share, 2017-2028
Figure 33. Turkey Liver Failure Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Liver Failure Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Liver Failure Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Liver Failure Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 37. Alfact Innovation Liver Failure Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. BioLineRx Ltd Liver Failure Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Cell2B Advanced Therapeutics SA Liver Failure Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Conatus Pharmaceuticals Inc Liver Failure Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Immune Pharmaceuticals Inc Liver Failure Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Mina Therapeutics Ltd Liver Failure Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Mylan NV Liver Failure Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Ocera Therapeutics Inc Liver Failure Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. PledPharma AB Liver Failure Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Promethera Biosciences SA Liver Failure Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Silence Therapeutics Plc Liver Failure Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Unicyte AG Liver Failure Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. Ventria Bioscience Liver Failure Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 50. Vital Therapies Inc Liver Failure Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)